LNP-mRNA vaccine prevents type 1 diabetes in non-obese diabetes mice

Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms

Akin Akinc, William Querbes, Soma De et al. · Molecular Therapy · 2010 · 1.2K citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

Kevan C. Herold, Brian N. Bundy, S. Alice Long et al. · New England Journal of Medicine · 2019 · 1.1K citations · Full text

Medicine, Immunology, Internal Medicine +17

Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes

Norbert Pardi, Steven Tuyishime, Hiromi Muramatsu et al. · Journal of Controlled Release · 2015 · 1K citations

Pharmacy, Molecular Biology, Molecular Pharmaceutics +17

Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA

Katalin Karikó, Hiromi Muramatsu, János Ludwig et al. · Nucleic Acids Research · 2011 · 884 citations · Full text

Life Sciences, Immunology, Molecular Biology +15

SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses

Jackson S. Turner, Jane A. O’Halloran, Elizaveta Kalaidina et al. · Nature · 2021 · 874 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14